vtm virtual therapeutic moeity actual therapeutic moeity atm vmp virtual medicinal product amp...
TRANSCRIPT
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Introduction of a datamodel
in the authentic source on medicines
(Acknowledgements: NHS, DM+D)
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
VTM
Atenolol Tenormin
ATM
VMPAtenolol
100 mg / O
AMPTenormin
100 mg
AMPPTenormin
100 mg 28 tablets
VMPPAtenolol 100 mg/O
3 – 5 x 7 units
Example : Atenonol 100 mg 28 tablets
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Vertical Distincition
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Pharmaco-therapeuticlevel
Vertical Distinction
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Pharmaco-therapeuticlevel
Trade level
Vertical Distinction
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Horizontal Distinction
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Active ingredient (or multiples)
Horizontal Distinction
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Strength
Horizontal Distinction
Active ingredient (or multiples)
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Strength
Pack Size
Horizontal Distinction
Active substance (or multiples)
Pack Size Aggregated
One shot
For 1 day
For 2 to 4 days
For 5 to 7 days
For x weeks
(multiples of 7 + 6 days)
Based on usual posology for the main indication for the main target group (usually an adult – of 70 kg-)
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Medicinal Product Package
Conditionement
Verpakking
INN-Cluster
Brandname (MP)
Tabel of content of repertorium
Link with more familiar concepts
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Five higher aggregations for the (actual) Medicinal Product Package
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
Three higher aggregrations for the Actual Medicinal Product
VTMVirtual
Therapeutic Moeity
Actual Therapeutic
Moeity
ATM
VMPVirtual
Medicinal Product
AMPActual
Medicinal Product
AMPP
Actual Medicinal Product Package
VMPP
Virtual Medicinal Product Package
One higher aggregation for VMPP, VMP en ATM
Identifying Characteristics of Aggregations
1) Virtual therapeutic moiety (VTM)
Primary key (+ HYR code ?)
INN_clustername
Application_area (high level abstraction of dosage form and administration route)
2) Actual therapeutic moiety (ATM)
Primary key (+ secondary key to VTM)
Idem +
MAH (possibly + licence holder)
Identifying Characteristics of Aggregations (cont.)
3) Virtual Medicinal Product (VMP)
Primary Key (+ secondary key to VTM)
VTM +
Strength_Pharmaceutical_Form (source FAGG)
4) Actual Medicinal Product (AMP)
Primary Key (+secondary keys to VTM, ATM, VMP)
VMP +
Marketing Authorisation Holder (possibly + licence holder)
Unit Pharmaceutical form
Registration information
Identifying Characteristics of Aggregations (cont.)
5) Virtual Medicinal Product Package (VMPP)
VMP +
Pack_size_aggregated (thesaurus controlled)
6) Actual Medicinal Product Package (AMPP)
See : basic elements
Medicinal Product Package
MPP
Active substance(s)
(1 or more)
Excipient(s)
(1 or more)
Higher aggregations
BASIC ELEMENTS TO BE DESCRIBED
Tools to describe
Basic Elements
Entities
Collections of descriptive characteristics
• Mandatory or optional
• Controlled by thesaurus or not
• Referring to external database or web site or not
• Based on law/regulation or not
Examples of Entities
Registration information
Price information
Reimbursement information
Doping information
Active Ingredient
Excipient
Strength
Dosage Form
Administration route
Pack Size
Outer package
Inner Package
Device
Trade name
MAH
Descriptive characteristics of the Basic Element : Active substance
Primary Key
CAS number (international database)
Active ingredient (entity)
INN – base
Salt / Acid / Ester
Molecular weight (number x unit)
INN_cluster_name (thesaurus controlled)
Descriptive characteristics of the Basic Element : Excipient
Primary Key
CAS number (international database)
Excipient_substance (entity)
Descriptive characteristics of the Basic Element : Actual Medicinal Product Package
Primary Key (+ secundary keys to 5 higher aggregations
Active ingredient (repetitive)
Excipient_substance (repetitive)
Pack Size (in pharmaceutical units, administration units, DDD)
Presentation_name
Outer package (from controlled thesaurus)
Inner Package (from controlled thesaurus)
Device (from controlled thesaurus)
Price information
Reimbursement information